Treatment of Keratoconus Using Collagen Cross-Linking

Status unconfirmed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Keratoconus

In brief

The purpose of this study is to determine the effectiveness of collagen cross-linking in the cornea in halting the progression and possibly partially reversing the effects of keratoconus. Keratoconus is a progressive weakening in the cornea that causes irregular astigmatism and thinning of the cornea. The overall effect is reduction of vision, and in more advanced cases, scarring of the cornea that may lead to the need for corneal transplantation. Cross-linking has been shown increase the rigidity of the cornea. The patients would be treated once and then followed over 24 months. .

Key facts

Study ID
NCT00841386
Run by
University at Buffalo
People needed
150
Starts
2008-09-01
Expected to finish
2011-12-01
Last updated by the study team
2009-02-11

Who can join

Age: 16 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.